Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-10-000019
Filing Date
2010-04-26
Accepted
2010-04-26 10:07:40
Documents
1
Period of Report
2010-04-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3004
  Complete submission text file 0000875320-10-000019.txt   4632
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 40 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
LEIDEN JEFFREY M (Reporting) CIK: 0001242825 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 10769193